beta Amyloid antibody (N-Term)
Quick Overview for beta Amyloid antibody (N-Term) (ABIN1105355)
Target
See all beta Amyloid (Abeta) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- N-Term
-
Specificity
- This antibody recognizes the N-terminal sequence (DAEFRHDS) of beta amyloid peptides, and full length beta amyloid peptide 40, 42 and 43.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human
-
Purification
- Protein G affinity purified
-
Immunogen
- Full length human beta amyloid peptide 42
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Use double distillated water to reconstitute the antibody.
-
Buffer
- 0.01 M PBS pH 7.2
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C.
-
-
- beta Amyloid (Abeta) (Amyloid beta (Abeta))
-
Alternative Name
- Amyloid beta
-
Background
- Beta amyloid, often abbreviated as A-beta, is a protein that builds up in the brains of persons with Alzheimer's disease, collecting in clumps called plaques or senile plaques. While some researchers question whether beta amyloid is the cause of the dementia, most agree that it is involved in the disruption of thinking that is a hallmark of the disease. In some cases of familial Alzheimer's disease, mutations in genes for the proteins called the presenilins lead to increased production of amyloid. Researchers have been looking at how presenilin-1 in particular contributes to the excess buildup of beta amyloid. Presenilin-1 apparently acts to increase the activity of gamma-secretase, an enzyme that changes a normal protein (amyloid precursor protein or APP) into beta amyloid itself. Furthermore, presenilin-1 might be gamma-secretase.
-
Gene ID
- 351
-
Pathways
- Inflammasome
Target
-